Allergic Triggers Associated With More Severe Asthma Exacerbations

CHEST Journal ◽  
2010 ◽  
Vol 138 (4) ◽  
pp. 310A ◽  
Author(s):  
Kathleen A. Sala ◽  
Alex M. Dressler ◽  
Taylor Aglio ◽  
Philip C. Spinella ◽  
Craig M. Schramm ◽  
...  
2006 ◽  
Vol 144 (12) ◽  
pp. 904 ◽  
Author(s):  
Shelley R. Salpeter ◽  
Nicholas S. Buckley ◽  
Thomas M. Ormiston ◽  
Edwin E. Salpeter

2006 ◽  
Vol 7 (6) ◽  
pp. 617
Author(s):  
Christopher L. Carroll ◽  
Anita Bhandari ◽  
Aaron R. Zucker ◽  
Craig M. Schramm

2020 ◽  
Vol 6 (4) ◽  
pp. 00147-2020
Author(s):  
Sangeetha Ramu ◽  
Jenny Calvén ◽  
Charalambos Michaeloudes ◽  
Mandy Menzel ◽  
Hamid Akbarshahi ◽  
...  

BackgroundAsthma exacerbations are commonly associated with rhinovirus (RV) infection. Interleukin-33 (IL-33) plays an important role during exacerbation by enhancing Type 2 inflammation. Recently we showed that RV infects bronchial smooth muscle cells (BSMCs) triggering production of interferons and IL-33. Here we compared levels of RV-induced IL-33 in BSMCs from healthy and asthmatic subjects, and explored the involvement of pattern-recognition receptors (PRRs) and downstream signalling pathways in IL-33 expression.MethodBSMCs from healthy and severe and non-severe asthmatic patients were infected with RV1B or stimulated with the PRR agonists poly(I:C) (Toll-like receptor 3 (TLR3)), imiquimod (TLR7) and poly(I:C)/LyoVec (retinoic acid-inducible gene 1 (RIG-I)/melanoma differentiation-associated protein 5 (MDA5)). Knockdown of TLR3, RIG-I and MDA5 was performed, and inhibitors targeting TBK1, nuclear factor-κB (NF-κB) and transforming growth factor (TGF)-β-activated kinase 1 (TAK1) were used. Gene and protein expression were assessed.ResultsRV triggered IL-33 gene and protein expression in BSMCs. BSMCs from patients with non-severe asthma showed higher baseline and RV-induced IL-33 gene expression compared to cells from patients with severe asthma and healthy controls. Furthermore, RV-induced IL-33 expression in BSMCs from healthy and asthmatic individuals was attenuated by knockdown of TLR3. Inhibition of TAK1, but not NF-κB or TBK1, limited RV-induced IL-33. The cytokine secretion profile showed higher production of IL-33 in BSMCs from patients with non-severe asthma compared to healthy controls upon RV infection. In addition, BSMCs from patients with non-severe asthma had higher levels of RV-induced IL-8, TNF-α, IL-1β, IL-17A, IL-5 and IL-13.ConclusionRV infection caused higher levels of IL-33 and increased pro-inflammatory and Type 2 cytokine release in BSMCs from patients with non-severe asthma. RV-induced IL-33 expression was mainly regulated by TLR3 and downstream via TAK1. These signalling molecules represent potential therapeutic targets for treating asthma exacerbations.


Allergy ◽  
2014 ◽  
Vol 69 (6) ◽  
pp. 775-783 ◽  
Author(s):  
K. Heikkilä ◽  
I. E. H. Madsen ◽  
S. T. Nyberg ◽  
E. I. Fransson ◽  
H. Westerlund ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document